PetMed Express, Inc. (PETS)
Stock Price Chart
Key Info
| Market Cap | 642.90M |
| Revenue (ttm) | 300.34M |
| Net Income (ttm) | 28.28M |
| Shares Out | 20.27M |
| EPS (ttm) | 1.42 |
| PE Ratio | 22.45 |
| Forward PE | 21.55 |
| Dividend | $1.12 |
| Dividend Yield | 3.51% |
Stock Quote
| Trading Day | Aug 7, 2020 |
| Last Price | $31.88 |
| Previous Close | $31.62 |
| Change ($) | 0.26 |
| Change (%) | 0.82% |
| Day's Open | 31.75 |
| Day's Range | 31.35 - 32.40 |
| Day's Volume | 684,192 |
| 52-Week Range | 15.12 - 42.89 |
More Stats
| Market Cap | 642.90M |
| Enterprise Value | 556.08M |
| Earnings Date (est) | Oct 26, 2020 |
| Ex-Dividend Date | May 14, 2020 |
| Shares Outstanding | 20.27M |
| Float | 17.68M |
| EPS (basic) | 1.41 |
| EPS (diluted) | 1.42 |
| FCF / Share | 1.27 |
| Dividend | $1.12 |
| Dividend Yield | 3.51% |
| Earnings Yield | 4.45% |
| FCF Yield | 3.94% |
| Payout Ratio | 77.30% |
| Shares Short | 6.36M |
| Short Ratio | 10.02 |
| Short % of Float | 37.84% |
| Beta | 0.63 |
| PE Ratio | 22.45 |
| Forward PE | 21.55 |
| P/FCF Ratio | 25.37 |
| PS Ratio | 2.14 |
| PB Ratio | 4.74 |
| Revenue | 300.34M |
| Operating Income | 34.25M |
| Net Income | 28.28M |
| Free Cash Flow | 25.34M |
| Net Cash | 86.82M |
| Net Cash / Share | 4.31 |
| Gross Margin | 27.05% |
| Operating Margin | 11.40% |
| Profit Margin | 9.40% |
| FCF Margin | 8.44% |
| ROA | 13.92% |
| ROE | 22.05% |
| ROIC | 105.50% |
Analyst Summary
Analyst Consensus: Underweight
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 284 | 283 | 274 | 249 | 235 | 229 | 233 | 228 | 238 | 232 |
| Revenue Growth | 0.25% | 3.51% | 9.88% | 6.18% | 2.31% | -1.71% | 2.44% | -4.37% | 2.85% | - |
| Gross Profit | 81.25 | 95.31 | 97.81 | 79.31 | 76.30 | 76.27 | 77.62 | 77.12 | 80.17 | 83.96 |
| Operating Income | 30.98 | 46.17 | 52.14 | 37.48 | 32.39 | 27.61 | 28.22 | 27.01 | 26.02 | 33.02 |
| Net Income | 25.85 | 37.74 | 37.28 | 23.82 | 20.57 | 17.45 | 17.97 | 17.17 | 16.66 | 20.87 |
| Shares Outstanding | 20.04 | 20.46 | 20.35 | 20.23 | 20.12 | 20.02 | 19.90 | 19.93 | 20.61 | 22.51 |
| Earnings Per Share | 1.29 | 1.84 | 1.82 | 1.17 | 1.02 | 0.87 | 0.90 | 0.86 | 0.80 | 0.92 |
| EPS Growth | -29.89% | 1.1% | 55.56% | 14.71% | 17.24% | -3.33% | 4.65% | 7.5% | -13.04% | - |
| Dividend Per Share | 1.08 | 1.06 | 0.85 | 0.76 | 0.72 | 0.68 | 0.66 | 0.60 | 0.53 | 0.48 |
| Dividend Growth | 1.89% | 24.71% | 11.84% | 5.56% | 5.88% | 3.03% | 10% | 14.29% | 10.53% | - |
| Operating Cash Flow | 38.84 | 45.14 | 37.38 | 47.20 | 21.05 | 32.04 | 13.51 | 13.29 | 20.39 | 30.11 |
| Capital Expenditures | -2.31 | -0.62 | -0.70 | -10.60 | -20.13 | -0.92 | -0.05 | -0.63 | -0.71 | -0.67 |
| Free Cash Flow | 36.53 | 44.52 | 36.68 | 36.60 | 0.92 | 31.13 | 13.46 | 12.66 | 19.69 | 29.44 |
| Cash & Equivalents | 104 | 101 | 77.94 | 58.73 | 37.64 | 51.20 | 33.84 | 33.65 | 57.15 | 59.78 |
| Net Cash / Debt | 104 | 101 | 77.94 | 58.73 | 37.64 | 51.20 | 33.84 | 33.65 | 57.15 | 59.78 |
| Assets | 155 | 154 | 135 | 113 | 90.28 | 82.85 | 78.38 | 73.18 | 91.06 | 106 |
| Liabilities | 25.31 | 19.75 | 19.11 | 19.44 | 7.08 | 7.42 | 8.16 | 9.17 | 9.88 | 9.28 |
| Book Value | 130 | 135 | 116 | 93.37 | 83.20 | 75.44 | 70.22 | 64.01 | 81.18 | 97.01 |
Company Profile
Company Details
| Full Name | PetMed Express, Inc. |
| Country | United States |
| Employees | 214 |
| CEO | Menderes Akdag |
Stock Information
| Ticker Symbol | PETS |
| Stock Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Unique Identifier | NASDAQ: PETS |
Description
PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventative, flea and tick preventative, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet website; telephone contact center; and direct mail/print through brochures and postcards. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.